These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25795257)

  • 1. C-reactive protein response to influenza vaccination as a model of mild inflammatory stimulation in the Philippines.
    McDade TW; Borja JB; Kuzawa CW; Perez TL; Adair LS
    Vaccine; 2015 Apr; 33(17):2004-8. PubMed ID: 25795257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein response to influenza vaccination predicts cardiovascular disease risk in the Philippines.
    McDade TW; Borja JB; Lee N; Aquino CT; Barrett T; Adair LS; Kuzawa CW
    Biodemography Soc Biol; 2020; 65(1):88-96. PubMed ID: 32065539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation.
    Posthouwer D; Voorbij HA; Grobbee DE; Numans ME; van der Bom JG
    Vaccine; 2004 Dec; 23(3):362-5. PubMed ID: 15530681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of influenza vaccine on markers of inflammation and lipid profile.
    Tsai MY; Hanson NQ; Straka RJ; Hoke TR; Ordovas JM; Peacock JM; Arends VL; Arnett DK
    J Lab Clin Med; 2005 Jun; 145(6):323-7. PubMed ID: 15976761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population differences in associations between C-reactive protein concentration and adiposity: comparison of young adults in the Philippines and the United States.
    McDade TW; Rutherford JN; Adair L; Kuzawa C
    Am J Clin Nutr; 2009 Apr; 89(4):1237-45. PubMed ID: 19225115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive antibody response to vaccination in adolescence predicts lower C-reactive protein concentration in young adulthood in the Philippines.
    McDade TW; Adair L; Feranil AB; Kuzawa C
    Am J Hum Biol; 2011; 23(3):313-8. PubMed ID: 21484910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute aerobic exercise on vaccine efficacy in older adults.
    Ranadive SM; Cook M; Kappus RM; Yan H; Lane AD; Woods JA; Wilund KR; Iwamoto G; Vanar V; Tandon R; Fernhall B
    Med Sci Sports Exerc; 2014 Mar; 46(3):455-61. PubMed ID: 23924918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with a history of stable or unstable coronary heart disease have different acute phase responses to an inflammatory stimulus.
    Werba JP; Veglia F; Amato M; Baldassarre D; Massironi P; Meroni PL; Riboldi P; Tremoli E; Camera M
    Atherosclerosis; 2008 Feb; 196(2):835-40. PubMed ID: 17335831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults.
    Glaser R; Robles TF; Sheridan J; Malarkey WB; Kiecolt-Glaser JK
    Arch Gen Psychiatry; 2003 Oct; 60(10):1009-14. PubMed ID: 14557146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
    Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M
    Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory response after influenza vaccination in men with and without carotid artery disease.
    Carty CL; Heagerty P; Nakayama K; McClung EC; Lewis J; Lum D; Boespflug E; McCloud-Gehring C; Soleimani BR; Ranchalis J; Bacus TJ; Furlong CE; Jarvik GP
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2738-44. PubMed ID: 17023683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of influenza vaccination on resting metabolic rate and c-reactive protein concentrations in healthy young adults.
    Parker CH; Sadhir S; Swanson Z; McGrosky A; Hinz E; Urlacher SS; Pontzer H
    PLoS One; 2023; 18(12):e0295540. PubMed ID: 38100425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).
    Taylor DN; Treanor JJ; Strout C; Johnson C; Fitzgerald T; Kavita U; Ozer K; Tussey L; Shaw A
    Vaccine; 2011 Jul; 29(31):4897-902. PubMed ID: 21596084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The longitudinal associations between C-reactive protein and depressive symptoms: evidence from the English Longitudinal Study of Ageing (ELSA).
    Au B; Smith KJ; Gariépy G; Schmitz N
    Int J Geriatr Psychiatry; 2015 Sep; 30(9):976-84. PubMed ID: 25537199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response.
    Taylor DN; Treanor JJ; Sheldon EA; Johnson C; Umlauf S; Song L; Kavita U; Liu G; Tussey L; Ozer K; Hofstaetter T; Shaw A
    Vaccine; 2012 Aug; 30(39):5761-9. PubMed ID: 22796139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
    Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
    Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
    Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.